Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Strategy for Patients With Rheumatoid Arthritis Associated Interstitial Lung Disease

NCT07643038 is registered in ClinicalTrials.gov with Chinese SLE Treatment And Research Group as lead sponsor.

NCT NCT07643038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07643038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Strategy for Patients With Rheumatoid Arthritis Associated Interstitial Lung Disease
Lead sponsor
Chinese SLE Treatment And Research Group
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 20, 2026
Completion date
July 31, 2029
Enrollment
204 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis associated interstitial lung disease